Rose Merc Limited Completes Equity Warrant Allotment and Major Corporate Restructuring
Rose Merc Limited successfully concluded its March 24, 2026 board meeting with major corporate developments including completion of equity warrant allotment worth ₹3.20 crores to 13 investors, strategic appointment of Vikas Phadnis as advisor, subsidiary restructuring with two companies transitioning to associate status, and acquisition of 48% stake in organic healthcare company Abaca Care Private Limited.

*this image is generated using AI for illustrative purposes only.
Rose Merc Limited has successfully completed its board meeting held on March 24, 2026, announcing significant corporate developments including the allotment of equity warrants, subsidiary status changes, and strategic appointments. The board meeting, which commenced at 4:00 PM and concluded at 5:45 PM, addressed multiple key agenda items in compliance with SEBI regulations.
Equity Warrant Allotment Completed
The company has successfully allotted 3,55,723 equity warrants convertible into equity shares on a preferential basis for cash. This follows the in-principal approval granted by BSE vide letter no. LOD/PREF/DA/FIP/1859/2025-26 dated March 11, 2026.
| Parameter: | Details |
|---|---|
| Total Warrants Allotted: | 3,55,723 |
| Issue Price per Warrant: | ₹90.00 (including premium of ₹80.00) |
| Total Consideration: | ₹3,20,15,070.00 |
| Amount Received (25%): | ₹80,03,767.50 |
| Conversion Period: | 18 months from allotment date |
Warrant Allottee Distribution
The warrants have been allocated among 13 investors across promoter and non-promoter categories. The largest individual allocation went to Tanveersingh Ahuja with 1,11,000 warrants, followed by Amitkumar Yogendra Singh and Niti Trivedi with 55,556 warrants each.
| Allottee Name: | Category | Warrants Allotted |
|---|---|---|
| Tanveersingh Ahuja: | Non-Promoter | 1,11,000 |
| Amitkumar Yogendra Singh: | Non-Promoter | 55,556 |
| Niti Trivedi: | Non-Promoter | 55,556 |
| Vikas Kamlakar Phadnis: | Non-Promoter | 50,000 |
| Vedika Thakur: | Non-Promoter | 40,000 |
| Vijay Acharya: | Non-Promoter | 30,000 |
| Kirti Chunilal Savla: | Promoter | 11,111 |
| Others (6 investors): | Non-Promoter | 2,250 |
| Total: | Both Categories | 3,55,723 |
Subsidiary Status Changes
The board approved significant changes in subsidiary holdings, resulting in two companies transitioning from subsidiary to associate status:
Rahi Pakhle RM Private Limited: Following director resignation from the board, the company's status changed to associate. The entity contributed ₹75,000 in revenue (0.009% of total) and had a net worth of ₹58,330 (0.017% of total).
Kaale and Rose Merc Advisors Private Limited: The board approved the sale of 49% equity stake for ₹49,000, along with director resignation, changing its status to associate company. The entity generated ₹5,70,000 in revenue (0.072% of total) with a negative net worth of ₹1,65,612.06.
| Company: | Revenue | Net Worth | Status Change |
|---|---|---|---|
| Rahi Pakhle RM Pvt Ltd: | ₹75,000 (0.009%) | ₹58,330 (0.017%) | Subsidiary to Associate |
| Kaale and Rose Merc Advisors: | ₹5,70,000 (0.072%) | -₹1,65,612.06 (-0.049%) | Subsidiary to Associate |
Strategic Appointments and New Acquisition
The board appointed Mr. Vikas Phadnis as Advisor-Strategy and Growth. Phadnis brings extensive experience as co-founder of Lighthouse Learning Group and has successfully built education enterprises over two decades.
Additionally, the company completed its investment in Abaca Care Private Limited, acquiring a 48% stake for ₹48,000. The target company operates in the organic healthcare sector, developing homeopathy pain relief products, and was incorporated on May 17, 2023.
| Investment Details: | Specifications |
|---|---|
| Target Company: | Abaca Care Private Limited |
| Stake Acquired: | 48% |
| Investment Amount: | ₹48,000 |
| Industry: | Organic healthcare |
| Status: | Now subsidiary of Rose Merc |
| Incorporation Date: | May 17, 2023 |
The comprehensive board meeting outcome reflects Rose Merc Limited's strategic focus on capital raising through warrant allotment while optimizing its subsidiary portfolio and strengthening advisory capabilities for future growth initiatives.
Historical Stock Returns for Rose Merc
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.19% | +0.36% | +0.13% | +4.44% | +55.40% | +1,778.23% |
What strategic initiatives will Rose Merc pursue with the ₹3.2 crore raised through warrant allotment, and how might this impact their market positioning?
How will the conversion of equity warrants over the next 18 months affect Rose Merc's shareholding structure and potential dilution for existing shareholders?
What synergies does Rose Merc expect to achieve through its 48% acquisition of Abaca Care in the organic healthcare sector?


































